These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25562729)

  • 1. Understanding the economic value of molecular diagnostic tests: case studies and lessons learned.
    Towse A; Ossa D; Veenstra D; Carlson J; Garrison L
    J Pers Med; 2013 Oct; 3(4):288-305. PubMed ID: 25562729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic incentives for evidence generation: promoting an efficient path to personalized medicine.
    Towse A; Garrison LP
    Value Health; 2013; 16(6 Suppl):S39-43. PubMed ID: 24034311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value added medicines: what value repurposed medicines might bring to society?
    Toumi M; Rémuzat C
    J Mark Access Health Policy; 2017; 5(1):1264717. PubMed ID: 28265347
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and health economic challenges of personalized medicine].
    Brüggenjürgen B; Kornbluth L; Ferrara JV; Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):710-4. PubMed ID: 22526860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming regulatory and economic challenges facing pharmacogenomics.
    Cohen JP
    N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melding regulatory, pharmaceutical industry, and U.S. payer perspectives on improving approaches to heterogeneity of treatment effect in research and practice.
    Willke RJ; Crown W; Del Aguila M; Cziraky MJ; Khan ZM; Migliori R
    Value Health; 2013; 16(6 Suppl):S10-5. PubMed ID: 24034306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking pharmacogenetics-based diagnostics and drugs for personalized medicine.
    Garrison LP; Austin MJ
    Health Aff (Millwood); 2006; 25(5):1281-90. PubMed ID: 16966724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a framework for personalized healthcare: lessons learned from the field of rare diseases.
    Tambuyzer E
    Per Med; 2010 Sep; 7(5):569-586. PubMed ID: 29776250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine.
    Akhmetov I; Bubnov RV
    EPMA J; 2015; 6():19. PubMed ID: 26425215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Market access challenges in the EU for high medical value diagnostic tests.
    Miller I; Ashton-Chess J; Spolders H; Fert V; Ferrara J; Kroll W; Askaa J; Larcier P; Terry PF; Bruinvels A; Huriez A
    Per Med; 2011 Mar; 8(2):137-148. PubMed ID: 29783414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cost-effective Laboratory: Implementation of Economic Evaluation of Laboratory Testing.
    Bogavac-Stanojevic N; Jelic-Ivanovic Z
    J Med Biochem; 2017 Sep; 36(3):238-242. PubMed ID: 30568540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.